SCHEMBL6290165

SCHEMBL6290165

[O]CCNC(=O)CCc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.66
L3MBTL1 Q9Y468 1/20 0.66
MEN1 O00255 1/20 0.64
RAB9A P51151 1/20 0.64
KMT2A Q03164 1/20 0.64
LMNA P02545 2/20 0.62
KDM4E B2RXH2 1/20 0.62
HDAC2 Q92769 3/20 0.61
HDAC8 Q9BY41 3/20 0.61
HDAC6 Q9UBN7 3/20 0.61
SMN1; SMN2 Q16637 1/20 0.60
GAA P10253 1/20 0.59
HDAC1 Q13547 3/20 0.58
HDAC3 O15379 2/20 0.58
HDAC10 Q969S8 2/20 0.58
HDAC11 Q96DB2 2/20 0.58
NCOR2 Q9Y618 2/20 0.58
HDAC4 P56524 1/20 0.58
HDAC9 Q9UKV0 1/20 0.58
MAPT P10636 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6290032 0.89 L3MBTL1 (0.72) HPGDL3MBTL1MEN1RAB9AKMT2A
SCHEMBL2186352 0.89 HDAC2 (0.72) HPGDL3MBTL1MEN1RAB9AKMT2A
SCHEMBL8744900 0.85 HPGD (0.81) HPGDL3MBTL1MEN1RAB9AKMT2A
SCHEMBL3681101 0.85 CNR2 (0.68) HPGDL3MBTL1MEN1RAB9AKMT2A
SCHEMBL3199145 0.85 LMNA (0.66) HPGDL3MBTL1MEN1RAB9AKMT2A
SCHEMBL2002639 0.84 L3MBTL1 (0.70) HPGDL3MBTL1MEN1RAB9AKMT2A
SCHEMBL4517102 0.84 HPGD (0.64) HPGDL3MBTL1MEN1RAB9AKMT2A
SCHEMBL7779895 0.84 HPGD (0.64) HPGDL3MBTL1MEN1RAB9AKMT2A
SCHEMBL10963359 0.84 HPGD (0.64) HPGDL3MBTL1MEN1RAB9AKMT2A
SCHEMBL6360887 0.84 HPGD (0.79) HPGDL3MBTL1MEN1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6867200-B1 (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-03-15 US disclosed